References
- Scholten W, Nygren-Krug H, Zucker HA. The World Health Organization paves the way for action to free people from the shackles of pain. Anesth Analg. 2007;105(1):1–4.
- Office for National Statistics. Deaths related to drug poisoning in England and Wales, 2017 registrations. London: Office for National Statistics; 2018 [cited 2020 Jul], Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2017registrations
- Advisory Council on the Misuse of Drugs. Reducing opioid-related deaths in the UK. London: Advisory Council on the Misuse of Drugs; Dec 2016 [cited 2020 Jul]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/576560/ACMD-Drug-Related-Deaths-Report-161212.pdf
- Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644–1656.
- Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. Atlanta: Centers for Disease Control and Prevention; 2011 [cited 2020 Jul]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm
- Torrance N, Mansoor R, Wang H, et al. Association of opioid prescribing practices with chronic pain and benzodiazepine co-prescription: a primary care data linkage study. Br J Anaesth. 2018;120(6):1345–1355.
- National Records of Scotland. Drug-related deaths in Scotland in 2018. Edinburgh: National Records of Scotland; Jul 2019 [cited 2020 Feb]. Available from: https://www.nrscotland.gov.uk/files/statistics/drug-related-deaths/2018/drug-related-deaths-18-pub.pdf
- European Monitoring Centre for Drugs and Drug Addiction. European drug report 2019: trends and developments. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; Jun 2019 [cited 2019 Jun]. Available from: http://www.emcdda.europa.eu/system/files/publications/11364/20191724_TDAT19001ENN_PDF.pdf
- National Health Service Scotland. National therapeutic indicators 2014/2015. Edinburgh: National Health Service Scotland; Oct 2014 [cited 2019 Jun]; Available from: https://www.sehd.scot.nhs.uk/publications/DC20141201nti.pdf
- National Health Service Scotland. Quality prescribing for chronic pain: a guide for improvement 2018-2021. Edinburgh: National Health Service Scotland; 2018 [cited 2020 Jun]; Available from: https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/03/Strategy-Chronic-Pain-Quality-Prescribing-for-Chronic-Pain-2018.pdf
- McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain. 2012;13(10):988–996.
- Chen TC, Chen LC, Kerry M, et al. Prescription opioids: regional variation and socioeconomic status - evidence from primary care in England. Int J Drug Policy. 2019;64:87–94.
- Curtis HJ, Croker R, Walker AJ, et al. Opioid prescribing trends and geographical variation in England, 1998-2018: a retrospective database study. Lancet Psychiatry. 2019;6(2):140–150.
- Mordecai L, Reynolds C, Donaldson LJ, et al. Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study. Br J Gen Pract. 2018;68(668):e225–e233.
- Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Clin Ther. 2013;35(3):303–311.
- Day C, Conroy E, Lowe J, et al. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users. Aust J Rural Health. 2006;14(3):120–125.
- Department of Health. Health survey for England - 2011: chapter 9, chronic pain London: Department of Health; 2012 [cited 2017 Jan]. Available from: http://content.digital.nhs.uk/catalogue/PUB09300
- National Health Service Scotland. Prescriptions in the community. Edinburgh: National Health Service Scotland; 2019 [cited 2019 Jun]. Available from: https://www.opendata.nhs.scot/dataset/prescriptions-in-the-community
- National Health Service Scotland. Practice list sizes by gender and age group. Edinburgh: National Health Service Scotland; Dec 2016. [cited 2019 Jun]. Available from https://www.isdscotland.org/Health-Topics/General-Practice/Publications/data-tables.asp?id=1805#1805
- National Health Service Scotland. Practice populations by deprivation status. Edinburgh: National Health Service Scotland; Dec 2016. [cited 2019 Jun]. Available from https://www.isdscotland.org/Health-Topics/General-Practice/Publications/data-tables.asp?id=1805#1805
- National Health Service Scotland. Practice populations by urban/rural classification. Edinburgh: National Health Service Scotland; Dec 2016. [cited 2019 Jun]. Available from https://www.isdscotland.org/Health-Topics/General-Practice/Publications/data-tables.asp?id=1805#1805
- National Health Service Scotland. Practice list sizes by gender and age group. Edinburgh: National Health Service Scotland; Dec 2018. [cited 2019 Jun]. Available from https://www.isdscotland.org/Health-Topics/General-Practice/Publications/data-tables2017.asp?id=2065#2065
- National Health Service Scotland. Practice populations by urban/rural classification. Edinburgh: National Health Service Scotland; Dec 2018. [cited 2019 Jun]. Available from https://www.isdscotland.org/Health-Topics/General-Practice/Publications/data-tables2017.asp?id=2065#2065
- National Health Service Scotland. 2015[2016] Achievement data at practice level - individual indicators. Edinburgh: National Health Service Scotland; Oct 2016 [cited 2019 Jun]. Available from: https://www.isdscotland.org/Health-Topics/General-Practice/Quality-And-Outcomes-Framework/2015-16/practice-level-individual-indicators.asp
- National Health Service Scotland. Practice populations by deprivation status. Edinburgh: National Health Service Scotland; Dec 2018. [cited 2019 Jun]. Available from https://www.isdscotland.org/Health-Topics/General-Practice/Publications/data-tables2017.asp?id=2065#2065
- World Health Organization. Anatomical therapeutic chemical/defined daily dose index 2016. Geneva: World Health Organization; Mar 2016 [cited 2020 Jul]. Available from http://www.whocc.no/atc_ddd_index/
- Bauer SR, Hitchner L, Harrison H, et al. Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting. Subst Abus. 2016;37(1):110–117.
- Foy R, Leaman B, McCrorie C, et al. Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics. BMJ open. 2016;6(5):e010276.
- Fredheim OM, Mahic M, Skurtveit S, et al. Chronic pain and use of opioids: a population-based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trondelag health study. Pain. 2014;155(7):1213–1221.
- Halbert BT, Davis RB, Wee CC. Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain. 2016;157(11):2452–2457.
- Sullivan MD, Edlund MJ, Fan MY, et al. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008;138(2):440–449.
- Sullivan MD, Edlund MJ, Zhang L, et al. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166(19):2087–2093.
- Bailey N, Flint J, Goodlad R, et al. Measuring deprivation in Scotland: developing a long-term strategy. Edinburgh: The Scottish Government; Sep 2003 [cited 2019 Jun]. Available from https://www.webarchive.org.uk/wayback/archive/20170701074158/http://www.gov.scot/Publications/2003/09/18197/26536
- National Records of Scotland. Mid-2018 population estimates Scotland. Edinburgh: National Records of Scotland; Apr 2019 [cited 2019 Jun]. Available from: https://www.nrscotland.gov.uk/files//statistics/population-estimates/mid-18/mid-year-pop-est-18-pub.pdf
- National Health Service Scotland. Quality & outcomes framework (QOF). Edinburgh: National Health Service Scotland; Oct 2016 [cited 2019 Jun]. Available from: https://www.isdscotland.org/Health-Topics/General-Practice/Quality-And-Outcomes-Framework/
- Snijders TAB. Multilevel analysis. In: Lovric M, editor. International encyclopedia of statistical science. Berlin (Heidelberg): Springer; 2011. p. 879–882.
- Silverman BW. A fast and efficient cross-validation method for smoothing parameter choice in spline regression. J Am Stat Assoc. 1984;79(387):584–589.
- Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–138.
- National Health Service Scotland. National therapeutic indicators 2018. Edinburgh: National Health Service Scotland; 2018 [cited 2020 Jun]. Available from: https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/08/National-Therapeutic-Indicators-Report-2018-19-Version-1.0.pdf
- Schofield J, Steven D, Foster R, et al. Quantifying prescribed high dose opioids in the community and risk of overdose. BMC Public Health. 2021 Jun 24;21(1):1174.
- Hill D, Marr E, Smith C. Development of pharmacist independent prescribing clinics to treat opioid analgesic dependence in NHS Lanarkshire. Pharmacy (Basel). 2019 Aug 22;7(3). DOI:10.3390/pharmacy7030119
- Prego-Domínguez J, Khazaeipour Z, Mallah N, et al. Socioeconomic status and occurrence of chronic pain: a meta-analysis. Rheumatology (Oxford). 2021 Mar 2;60(3):1091–1105.
- Poleshuck EL, Green CR. Socioeconomic disadvantage and pain. Pain. 2008 Jun;136(3):235–238.
- Chen TC, Chen LC, Knaggs RD. A 15-year overview of increasing tramadol utilisation and associated mortality and the impact of tramadol classification in the United Kingdom. Pharmacoepidemiol Drug Saf. 2017;27(5):487–494.
- Dave CV, Patorno E, Franklin JM, et al. Impact of state laws restricting opioid duration on characteristics of new opioid prescriptions. J Gen Intern Med. 2019;34(11):2339–2341.
- Wettermark B, Godman B, Jacobsson B, et al. Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences. Appl Health Econ Health Policy. 2009;7(3):137–147.
- Manasco AT, Griggs C, Leeds R, et al. Characteristics of state prescription drug monitoring programs: a state-by-state survey. Pharmacoepidemiol Drug Saf. 2016;25(7):847–851.
- Ashburn MA. The evolution of prescription drug monitoring programs. Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):852–853.
- Public Health Scotland. View the atlas-surgical procedures 2020 [cited Jan 2022]. Available from: https://www.isdscotland.org/products-and-services/scottish-atlas-of-variation/view-the-atlas/surgical-procedures.asp
- Public Health Scotland. View the atlas-mental health 2020 [cited Jan 2022]. Available from: https://www.isdscotland.org/products-and-services/scottish-atlas-of-variation/view-the-atlas/mental-health.asp
- Public Health Scotland. Chronic pain waiting times. Edinburgh: Public Health Scotland; 2020 [cited 2020 Jun]. Available from: https://beta.isdscotland.org/find-publications-and-data/healthcare-resources/waiting-times/chronic-pain-waiting-times/
- National Health Service Digital. General practitioner practice prescribing presentation-level data. Leeds: National Health Service Digital; [cited 2016 Feb]. Available from: http://content.digital.nhs.uk/searchcatalogue?topics=1%2fPrescribing%2fPrimary+care+prescribing&sort=Relevance&size=10&page=1#top
- National Health Service Digital. Quality and outcomes framework (QOF) - 2014-15. Leeds: National Health Service Digital; 2015 [cited 2016 Jun]. Available from: http://content.digital.nhs.uk/catalogue/PUB18887